LEAXOLAR CAPSULES 150 mg
Product details
Registration number: SIN17424P
Classification: Prescription Only
Active ingredients: Dabigatran etexilate mesilate eqv dabigatran etexilate
Strength: 150 mg
Dosage form: CAPSULE
Route: ORAL
Registrant: LOTUS INTERNATIONAL PTE. LTD.
ATC code: B01AE07
HSA approval date: 31 December 2025
Manufacturer(s): OMAN PHARMACEUTICAL PRODUCTS COMPANY LLC
Manufacturing country/countries: OMAN
What are the HSA registration number and classification for LEAXOLAR CAPSULES 150 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17424P
Classification: Prescription Only
What active ingredients and strength are recorded for LEAXOLAR CAPSULES 150 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Dabigatran etexilate mesilate eqv dabigatran etexilate
Strength: 150 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for LEAXOLAR CAPSULES 150 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for LEAXOLAR CAPSULES 150 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: LOTUS INTERNATIONAL PTE. LTD.
Which manufacturers and countries are listed for LEAXOLAR CAPSULES 150 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): OMAN PHARMACEUTICAL PRODUCTS COMPANY LLC
Manufacturing country/countries: OMAN
Where can I look up LEAXOLAR CAPSULES 150 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17424P or the exact product name LEAXOLAR CAPSULES 150 mg. The general register link does not preselect this product.
What are the source dates for this LEAXOLAR CAPSULES 150 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this LEAXOLAR CAPSULES 150 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17424P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)